Cargando…

Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression

Apart from indolent systemic mastocytosis (SM), which is associated with a favorable prognosis, other subtypes of SM (SM with associated clonal hematologic non–mast cell lineage disease, aggressive SM, and mast cell leukemia – collectively referred to in this review as advanced SM) can be debilitati...

Descripción completa

Detalles Bibliográficos
Autor principal: Verstovsek, Srdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3761194/
https://www.ncbi.nlm.nih.gov/pubmed/23181448
http://dx.doi.org/10.1111/ejh.12043